Analyses of publicly available transcriptomic dataset from HCC patients (Figure S12A) further indicate that a significant proportion of HCC patients exhibit high levels of FGF21, but low levels of AHSG, ANGPTL4, FETUB and LECT2 in HCC tissue as compared to matched non-tumoral tissue. Here, FGF21 is linked to hepatocellular carcinoma.